Corneal Diseases, Glaucoma, Healthy, Retinal Disease
Conditions
Brief summary
The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes
Interventions
DEVICEOCT
A10900 is an optical coherence tomography device
Sponsors
Optos, PLC
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Inclusion/
Exclusion criteria
Inclusion Criteria for Retinal Disease Group 1. Participants 22 years of age or older on the date of informed consent 2. Participants able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. BCVA 20/400 or better in the study eye 4. Participants presenting at the site with retinal disease 5. Diagnosis of some type of retinal pathology by investigator, may include, but not limited to: Macular Degeneration (including participants with drusen and geographic atrophy and choroidal neovascularization), Diabetic Macular Edema, Diabetic Retinopathy, Macular Hole, Epiretinal Membrane, Central Serous Retinopathy and others
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of OCT Scans | 1 year |
Countries
United States
Outcome results
None listed